Multiple moving parts have caused a shortage of eggs, starting with avian influenza and demand, David Murray writes.

The US Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) has issued a conditional license for an avian influenza vaccine, H5N2 subtype, killed virus. The vaccine, manufactured by Zoetis, is labeled for use in chickens.

Three years into a nationwide avian influenza outbreak that has forced millions of egg-laying birds to be killed after becoming infected, Hilliker’s Ranch in Lakeside has been able to keep producing day in and day out with a little luck and a lot of effort around sanitation.

PARSIPPANY, N.J., February 14, 2025--(BUSINESS WIRE)--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype ...

Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE:ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens. The conditional license was granted on the demonstration of safety,

The vaccine from Zoetis, Avian Influenza Vaccine, H5N2 Subtype, Killed Virus, is for poultry and has been demonstrated to be safe, pure, and to have a reasonable expectation of efficacy

Spearheaded by National Economic Council Director Kevin Hassett and USDA Secretary Brooke Rollins, the plan prioritizes enhanced biosecurity measures and medication to control the spread of the virus and moves away from mass culling of infected flocks.

A veterinary pharmaceutical company said they have received a conditional license for a bird flu vaccine to be used on chickens, potentially marking the first step toward mitigating a disease that has affected more than 150 million birds in the United States since 2022.

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license